Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bcl-2 expressing prostate cancer cells to irradiation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/content/pdf/10.1007/s00345-008-0289-5.pdf
Reference32 articles.
1. Jemal A, Siegel R, Ward E et al (2007) Cancer statistics. CA Cancer J Clin 57:43–66
2. Merrill RM, Brawley OW (1997) Prostate cancer incidence and mortality rates among white and black men. Epidemiology 8:126–131
3. Shipley WU, Verhey LJ, Munzenrider JE et al (1995) Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radat Oncol Biol Phys 32:3–12
4. Pollack A, Zagars GK, Starkschall G et al (1996) Conventional vs. conformal radiotherapy for prostate cancer. Preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys 34:555–564
5. Bagshaw MA, Kaplan ID, Cox RC (1993) Prostate cancer. Radiation therapy for localized disease. Cancer 71:939–952
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use;American Journal of Cancer Research;2024
2. Radiation-sensitive genetic prognostic model identifies individuals at risk for radiation resistance in head and neck squamous cell carcinoma;Journal of Cancer Research and Clinical Oncology;2023-09-01
3. Suppression Effects of Excessively Expressed Gene BCL-2 in Cell Lines of Prostate Cancer;Macedonian Veterinary Review;2022-10-01
4. Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas;Neuro-Oncology;2022-08-17
5. In HPV-Positive HNSCC Cells, Functional Restoration of the p53/p21 Pathway by Proteasome Inhibitor Bortezomib Does Not Affect Radio- or Chemosensitivity;Translational Oncology;2019-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3